Achievement of tolerance induction to prevent acute graft-vs.-host disease

Govindarajan Thangavelu, Bruce R. Blazar

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations


Acute graft-vs.-host disease (GVHD) limits the efficacy of allogeneic hematopoietic stem cell transplantation (allo-HSCT), a main therapy to treat various hematological disorders. Despite rapid progress in understanding GVHD pathogenesis, broad immunosuppressive agents are most often used to prevent and remain the first line of therapy to treat GVHD. Strategies enhancing immune tolerance in allo-HSCT would permit reductions in immunosuppressant use and their associated undesirable side effects. In this review, we discuss the mechanisms responsible for GVHD and advancement in strategies to achieve immune balance and tolerance thereby avoiding GVHD and its complications.

Original languageEnglish (US)
Article number309
JournalFrontiers in immunology
Issue numberMAR
StatePublished - 2019

Bibliographical note

Funding Information:
This work was supported by grants from the National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Heart, Lung, and Blood Institute, and National Cancer Institute R01 HL56067, HL1181879, and AI34495 (BB). GT was supported by the Canadian Institutes of Health Research (CIHR) fellowship.

Publisher Copyright:
© 2019 Thangavelu and Blazar. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.


  • Allogeneic hematopoietic stem cell transplantation
  • Alpha-1 antitrypsin
  • Graft-vs.-host disease
  • Immune tolerance
  • T regulatory cells


Dive into the research topics of 'Achievement of tolerance induction to prevent acute graft-vs.-host disease'. Together they form a unique fingerprint.

Cite this